← Eichor
Study identifier: NCT05159349 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mental Health During the Whole Life Cycle of Community Patients With Schizophrenia

Condition: Schizophrenia  ·  Sponsor: Shanghai Mental Health Center

PhaseN/A
Planned participants1200
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Schizophrenia is one of the components of severe mental disorders. It has the characteristics of prolonged course, low cure rate, high recurrence rate and high disability rate. It brings many short-term and long-term effects to individuals, families and society. Studies on patients with schizophrenia mainly focus on cross-sectional and case-control studies, but there is a lack of long-term follow-up of patients with schizophrenia in the community. Therefore, this study would establish a cohort study to solve the chronological relationship between exposure and effect, focus on community schizophrenia, and establish a community schizophrenia patient biobank that has been tracked for a long time from diagnosis.

This description comes directly from the study's public registry record.

Talk to the study team

Weibo Zhang  ·  86-18918516651  ·  zhangweibo600@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Mental Health CenterShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05159349